MBC BioLabs Longevity Innovation Forum
Join us for our fifth Innovation Forum, where we'll highlight pioneering startups reimagining how we prevent and treat age-related disease. Together, we’re bringing the longevity community of founders, funders, and partners driving the future of healthspan.
Agenda
3:00 – 3:30 PM: Doors open / registration
3:30 – 3:40 PM: Welcome & Introductory Remarks by Leah Makley
3:40 – 4:10 PM: Keynote Presentation
Gordian Biotechnology: Discovering new therapies for complex age-related disease.
4:10 – 4:20 PM: Featured Investor Introductions: Zak Doric (a16z Bio + Health), Amalia Colangelo (Two Bear Capital), Clay Rowland (Mission BioCapital), Alex Colville (age1), Tim Luker (Lilly Ventures)
4:20 – 4:50 PM: Pitches
Arda Therapeutics: Taking aim at chronic diseases by eliminating the pathogenic cells that drive them.
Permanence Bio: Protecting the genome.
4:50 – 5:30 PM: Posters Networking Break
5:30 – 7:00 PM: Pitches
Cavalry: Engineering targeted growth factors.
General Control Biotechnologies: Engineering epigenetic medicines for the complexity of age-related diseases.
Deciduous Therapeutics: Developing a novel class of immune-modulatory therapies designed to promote healthy lifespan.
Euler Biologics: Antibody-based drugs keeping older adults stronger for longer.
Adjuvia Therapeutics: Harnessing the power of nature's designs.
Matter Bio: Promoting longevity through DNA information preservation.
7:00 – 7:30 PM: Reception
Our poster session will showcase additional emerging technologies from Sculpta Bio, Rejoovenate Bio, NeuroAge Therapeutics, Cerepeut, Inapill, Aperture Therapeutics, Lento Bio, Reservoir Neuroscience, Inixi Bio, and Cyclarity Therapeutics.
This is an invitation-only event with a thoughtfully curated group of investors, business development teams, and longevity founders shaping the landscape. Expect meaningful dialogue, new connections, and startups presenting what’s next in the science of aging.